BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21093830)

  • 1. Invasive ductal carcinoma arising in phyllodes tumor with isolated tumor cells in sentinel lymph node.
    Kuo YJ; Ho DM; Tsai YF; Hsu CY
    J Chin Med Assoc; 2010 Nov; 73(11):602-4. PubMed ID: 21093830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node identification in a primary ductal carcinoma arising in the vulva.
    Martinez-Palones JM; Perez-Benavente A; Diaz-Feijoo B; Gil-Moreno A; Roca I; García-Jimenez A; Aguilar-Martinez I; Xercavins J
    Int J Gynecol Cancer; 2007; 17(2):471-7. PubMed ID: 17362321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive Ductal Carcinoma within a Benign Phyllodes Tumor.
    Panko N; Jebran AA; Gomberawalla A; Connolly M
    Am J Case Rep; 2017 Jul; 18():813-816. PubMed ID: 28724885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ductal carcinoma in situ with isolated tumor cells in the sentinel lymph node in a 17-year-old adolescent girl.
    Sato T; Muto I; Hasegawa M; Aono T; Sakai T; Oya T
    Breast Cancer; 2013 Jul; 20(3):271-4. PubMed ID: 20411367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerosing adenosis in sentinel axillary lymph nodes from a patient with invasive ductal carcinoma: an unusual variant of benign glandular inclusions.
    Chen YB; Magpayo J; Rosen PP
    Arch Pathol Lab Med; 2008 Sep; 132(9):1439-41. PubMed ID: 18788857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
    Yen TW; Hunt KK; Ross MI; Mirza NQ; Babiera GV; Meric-Bernstam F; Singletary SE; Symmans WF; Giordano SH; Feig BW; Ames FC; Kuerer HM
    J Am Coll Surg; 2005 Apr; 200(4):516-26. PubMed ID: 15804465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant phyllodes tumour with intraductal and invasive carcinoma and lymph node metastasis.
    Korula A; Varghese J; Thomas M; Vyas F; Korula A
    Singapore Med J; 2008 Nov; 49(11):e318-21. PubMed ID: 19037540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive ductal breast cancer within a malignant phyllodes tumor: case report and assessment of clonality.
    Macher-Goeppinger S; Marme F; Goeppert B; Penzel R; Schirmacher P; Sinn HP; Aulmann S
    Hum Pathol; 2010 Feb; 41(2):293-6. PubMed ID: 19896695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
    Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H
    Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of breast carcinoma cases with false-negative sentinel lymph nodes.
    Wei S; Bleiweiss IJ; Nagi C; Jaffer S
    Clin Breast Cancer; 2014 Aug; 14(4):280-4. PubMed ID: 24581736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collision tumor with inflammatory breast carcinoma and malignant phyllodes tumor: a case report and literature review.
    Shin YD; Lee SK; Kim KS; Park MJ; Kim JH; Yim HS; Choi YJ
    World J Surg Oncol; 2014 Jan; 12():5. PubMed ID: 24400686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma.
    Durak MG; Akansu B; Akin MM; Sevınç AI; Koçdor MA; Saydam S; Harmancioğlu O; Ellıdokuz H; Bekış R; Canda T
    Turk Patoloji Derg; 2011; 27(3):189-95. PubMed ID: 21935867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant phyllodes tumour and homolateral breast cancer.
    Auerbach L
    Lancet Oncol; 2002 May; 3(5):279. PubMed ID: 12067804
    [No Abstract]   [Full Text] [Related]  

  • 14. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
    Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
    Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ.
    Wilkie C; White L; Dupont E; Cantor A; Cox CE
    Am J Surg; 2005 Oct; 190(4):563-6. PubMed ID: 16164920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph Node and Distant Metastases in Phyllodes Tumor of the Breast.
    Naal T; Saker S; Coldren D
    Int J Surg Pathol; 2023 Aug; 31(5):761-764. PubMed ID: 36285397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phyllodes breast tumour showing invasive squamous-cell carcinoma with invasive ductal, clear-cell, secretory, and squamous components.
    Ramdass MJ; Dindyal S
    Lancet Oncol; 2006 Oct; 7(10):880. PubMed ID: 17012052
    [No Abstract]   [Full Text] [Related]  

  • 18. Ductal carcinoma in-situ arising within benign phyllodes tumours.
    Lui SA; Oh HB; Wang S; Chan CW
    Ann R Coll Surg Engl; 2018 Apr; 100(4):e97-e102. PubMed ID: 29484937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel Lymph Node Biopsy and Isolated Tumor Cells in Invasive Lobular Versus Ductal Breast Cancer.
    Truin W; Roumen RM; Siesling S; van der Heiden-van der Loo M; Lobbezoo DJ; Tjan-Heijnen VC; Voogd AC
    Clin Breast Cancer; 2016 Aug; 16(4):e75-82. PubMed ID: 27116948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indocyanine green fluorescence mapping for sentinel lymph node biopsy in early breast cancer.
    Pitsinis V; Provenzano E; Kaklamanis L; Wishart GC; Benson JR
    Surg Oncol; 2015 Dec; 24(4):375-9. PubMed ID: 26555151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.